Advertisement
OBSTETRICS| Volume 116, ISSUE 7, P895-900, August 01, 1973

Screening criteria for high-risk gestational diabetic patients

  • John B. O'Sullivan
    Correspondence
    Diabetes and Arthritis Unit, Boston University Medical Center, 408 Atlantic Ave., Room 307, Boston, Massachusetts 02210
    Affiliations
    From the Departments of Obstetrics and Medicine (Section on Preventive Medicine and Epidemiology), Boston University and Boston City Hospital, Boston, Massachusetts.
    Search for articles by this author
  • Clare M. Mahan
    Affiliations
    From the Departments of Obstetrics and Medicine (Section on Preventive Medicine and Epidemiology), Boston University and Boston City Hospital, Boston, Massachusetts.
    Search for articles by this author
  • David Charles
    Affiliations
    From the Departments of Obstetrics and Medicine (Section on Preventive Medicine and Epidemiology), Boston University and Boston City Hospital, Boston, Massachusetts.
    Search for articles by this author
  • Robert V. Dandrow
    Affiliations
    From the Departments of Obstetrics and Medicine (Section on Preventive Medicine and Epidemiology), Boston University and Boston City Hospital, Boston, Massachusetts.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Clinical history, including previous abnormal pregnancy history, birth of a large baby, maternal obesity, and family history of diabetes, is demonstrated to be an insensitive screening factor in the selection of gestational diabetic patients. A screening blood sugar test and the age of the prenatal patient appear as the two most important of the factors studied for the identification of the gestational diabetic patient. A one-hour screening blood sugar test following oral ingestion of 50 Gm. of glucose and a glucose tolerance test on those patients with levels exceeding 130 mg. per 100 ml. of whole blood
      Approximate equivalent for plasma or freshly separated serum is 150 mg. per 100 ml.
      *Approximate equivalent for plasma or freshly separated serum is 150 mg. per 100 ml.
      are recommended. For the gestational diabetic patient at special risk for a current pregnancy, this procedure should be carried out in all patients 25 years or older.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • O’Sullivan J.B.
        • Charles D.
        • Dandrow R.V.
        J. Reprod. Med. 1971; 7: 21
        • O’Sullivan J.B.
        • Charles D.
        • Mahan C.M.
        • Dandrow R.V.
        Am. J. Obstet. Gynecol. 1973; 116: 901
        • Wilkerson H.L.C.
        • O’Sullivan J.B.
        Diabetes. 1963; 12: 313
        • O’Sullivan J.B.
        • Mahan C.M.
        Diabetes. 1964; 13: 278
        • O’Sullivan J.B.
        • Kantor N.
        Public Health Rep. 1963; 78: 1023
        • Thorner R.M.
        • Remein Q.R.
        Principles and Procedures in the Evaluation of Screening for Disease, Public Health Service Publication No. 846. United States Government Printing Office, Washington1961
        • Miller H.C.
        • Hurwitz D.
        • Kuder K.
        J. A. M. A. 1944; 124: 271
        • Moss J.M.
        • Mulholland H.B.
        Ann. Intern. Med. 1951; 34: 678
        • Jackson W.P.U.
        Br. Med. J. 1952; 2: 690